Hiroaki Suga’s research has made substantial contributions to the development of artificial ribozymes and their application in mRNA display libraries. In 2006, Professor Suga help found the biopharmaceutical company PeptiDream Inc. He spoke to Nature Chemical Biology about the future of mRNA display libraries and the advantages they offer.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Johnson, R. Putting peptides on display. Nat Chem Biol 20, 1–2 (2024). https://doi.org/10.1038/s41589-023-01494-0
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41589-023-01494-0